ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 69 filers reported holding ALBIREO PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,944,000 | -62.4% | 147,211 | -39.4% | 0.51% | -45.8% |
| Q2 2019 | $7,834,000 | +0.1% | 242,978 | 0.0% | 0.94% | -0.4% |
| Q1 2019 | $7,826,000 | +38.7% | 242,978 | +5.7% | 0.94% | +22.7% |
| Q4 2018 | $5,641,000 | -9.7% | 229,978 | +21.3% | 0.77% | +15.7% |
| Q3 2018 | $6,248,000 | +1.8% | 189,578 | +9.7% | 0.66% | -3.4% |
| Q2 2018 | $6,135,000 | +9.0% | 172,803 | 0.0% | 0.69% | +11.2% |
| Q1 2018 | $5,628,000 | -9.5% | 172,803 | -28.8% | 0.62% | -20.6% |
| Q4 2017 | $6,216,000 | +87.7% | 242,803 | +53.6% | 0.78% | +82.0% |
| Q3 2017 | $3,311,000 | -14.8% | 158,027 | -16.3% | 0.43% | +0.5% |
| Q2 2017 | $3,887,000 | +701.4% | 188,712 | +833.1% | 0.42% | +645.6% |
| Q1 2017 | $485,000 | – | 20,224 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
| Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
| Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
| SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
| BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
| Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
| PA Capital LLC | 14,692 | $360,000 | 0.38% |
| Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
| Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |